Status:
UNKNOWN
Effect of Short-term Synbiotic Treatment on Plasma P-cresol Levels in Hemodialysis Patients
Lead Sponsor:
Federico II University
Conditions:
Hemodialysis
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The interest on gastrointestinal (GI) dysfunction in hemodialysis has been growing in the last years. it is now accepted that GI dysfunction in dialyzed patients may contribute to systemic microinflam...
Detailed Description
In patients with end stage renal disease, alterations in gut microbioma are posited to be responsible for gastrointestinal symptoms and generation of p-cresol, a uremic toxin, that has been associated...
Eligibility Criteria
Inclusion
- hemodialysis
- age \>18 years
Exclusion
- severe infections
- diabetes
- malignancy
- history of food intolerance
- autoimmune disorders
- severe malnutrition
- clinical conditions requiring artificial feeding
- kidney transplant
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02311868
Start Date
December 1 2014
End Date
February 1 2015
Last Update
December 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
federico II university, department of nephrology
Naples, Italy, Italy, 80131